CBD Life Sciences Inc.
CBDL
$0.0004
$0.000.00%
| 03/31/2024 | 03/31/2023 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Net Income | -52.40K | -23.50K | -283.50K | -1.33M | -1.33M |
| Total Depreciation and Amortization | 18.50K | 18.50K | 11.60K | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | 1.70K | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -- | -- |
| Change in Net Operating Assets | 31.40K | 5.50K | -57.00K | -45.00K | -45.00K |
| Cash from Operations | -2.40K | 500.00 | -327.20K | -1.37M | -1.37M |
| Capital Expenditure | -- | -- | -34.50K | -8.00K | -8.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -8.30K | -8.30K |
| Cash from Investing | -- | -- | -34.50K | -16.20K | -16.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 1.67M | 1.67M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | 1.67M | 1.67M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.40K | 500.00 | -361.70K | 277.80K | 277.80K |
